Akron collaborates with Vivex Biomedical on usage of next-generation line of cryopreservation media Akron is pleased to announce that it secured a strategic collaboration with Vivex Biomedical, Inc. Vivex Biomedical, Inc., from Marietta, GA, designs and develops innovative biologic items for regenerative medicine applications. Tracy Anderson, Vivex CEO, speaks to the imperative, ‘Vivex underscores its dedication to patient care in the confidence that only the highest quality products become therapeutic choices. Our collaboration with Akron Biotech meets those requirements of excellence.’ Related StoriesLiposomal sizing and the Coulter principle: an interview with Professor Melvin E. KlegermanJumping genes: a marker for early cancers medical diagnosis? Akron's Claudia Zylberberg said, ‘We are really pleased to lengthen our new line of DMSO-free of charge cryomedia toward exciting and important new applications, and the collaboration with Vivex is a primary exemplory case of the potential and need for improved cryopreservation solutions which Akron pioneered.Each and every part of me itched. After many weeks and several trips to experts, Spurlock was informed it could be anything from food allergy symptoms to her medicine. But no matter what she changed, the symptoms persisted and Spurlock resigned herself to a lifestyle of misery. I just sort of thought that's what life was going to end up like, she said. Then, a mobile phone was got by her call. I had a Family pet scan for a lung problem and they stated, 'Paula, what's going on with your best hip?' I informed them I acquired it replaced plus they said, 'Well, it lights up on your dog scan.' Greater than a year after it had been implanted, assessments showed Paula was extremely allergic to the metal in her new hip also to the surgical cement often used to hold joints in place.